Development of Biotechnological Photosensitizers for Photodynamic Therapy: Cancer Research and Treatment—From Benchtop to Clinical Practice (scientific article published on 13 October 2022)

Cellular localization of tolyporphins, unusual tetrapyrroles, in a microbial photosynthetic community determined using hyperspectral confocal fluorescence microscopy.

Q67407395

Polyacrylamide Nanoparticles as a Delivery System in Photodynamic Therapy

Q83629835

Porphyrins and related macrocycles: Combining photosensitization with radio- or optical-imaging for next generation theranostic agents

Q90230231

Production and extraction of carotenoids produced by microorganisms

Q90602333

Fungal Pigments and Their Prospects in Different Industries

Q91446025

Photodynamic Therapy for Cancer: What's Past is Prologue

Q91839340

Two cases of bile duct carcinoma patients who underwent the photodynamic therapy using talaporfin sodium (Laserphyrin®)

Q92921697

Hypocrellin A-based photodynamic action induces apoptosis in A549 cells through ROS-mediated mitochondrial signaling pathway

Q93015049

Nanotechnology-based photoimmunological therapies for cancer

Q93373142

Natural photosensitizers in Photodynamic Therapy: in vitro activity against monolayers and spheroids of human colorectal adenocarcinoma SW480 cells

Q96680843

Host-guest complexes - boosting the performance of photosensitizers

Q97094060

Current applications of drug delivery nanosystems associated with antimicrobial photodynamic therapy for oral infections

Q102060932

Genetically Encoded Red Photosensitizers with Enhanced Phototoxicity

Q102376637

6-Nitro-Quinazolin-4(3H)-one Exhibits Photo-Dynamic Effects and Photo-Degrades Human Melanoma Cell Lines. A Study on the Photo-Reactivity of Simple Quinazolin-4(3H)-ones

Q104692727

Targeted isolation of photoactive pigments from mushrooms yielded a highly potent new photosensitizer: 7,7′-biphyscion

Q110656312

Some Natural Photosensitizers and Their Medicinal Properties for Use in Photodynamic Therapy

Q114864363

Production of sodium copper chlorophyllin from a green microalga Chlorella minutissima: a value-added co-product for sustainable microalgal refinery

Q115210649

Current developments on the application of microbial carotenoids as an alternative to synthetic pigments

Q125590219

Photodynamic therapy in cancer treatment - an update review

Q128152079

Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT.

Q33437363

Silicon phthalocyanine (pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial

Q33796958

A delivery system to avoid self-aggregation and to improve in vitro and in vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy.

Q33962996

Chlorophyll derivative mediated PDT versus methotrexate: An in vitro study using MCF-7 cells

Q34496965

The effect of Radachlorin® PDT in advanced NSCLC: a pilot study.

Q34774138

Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide-a for early-stage cancer of the larynx: Phase Ib study

Q35842215

Sinoporphyrin sodium mediated photodynamic therapy inhibits the migration associated with collapse of F-actin filaments cytoskeleton in MDA-MB-231 cells

Q35888324

New photosensitizers for photodynamic therapy

Q35919257

Photodynamic action of palmatine hydrochloride on colon adenocarcinoma HT-29 cells

Q36018285

Optimization of yeast-based production of medicinal protoberberine alkaloids.

Q36070938

Palmatine hydrochloride mediated photodynamic inactivation of breast cancer MCF-7 cells: Effectiveness and mechanism of action

Q36083488

Disulfonated tetraphenyl chlorin (TPCS2a)-induced photochemical internalisation of bleomycin in patients with solid malignancies: a phase 1, dose-escalation, first-in-man trial

Q36090820

Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models

Q36248532

In vivo Biocompatibility, Biodistribution and Therapeutic Efficiency of Titania Coated Upconversion Nanoparticles for Photodynamic Therapy of Solid Oral Cancers.

Q37202303

Aluminum-phthalocyanine chloride associated to poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as a new third-generation photosensitizer for anticancer photodynamic therapy

Q37635409

Biotechnological production of astaxanthin with Phaffia rhodozyma/Xanthophyllomyces dendrorhous

Q37806670

HYPERICIN CYTOTOXICITY IN TUMOR AND NON-TUMOR CELL LINES: A CHEMOMETRIC STUDY.

Q38623233

Silicon(IV) phthalocyanines substituted axially with different nucleoside moieties. Effects of nucleoside type on the photosensitizing efficiencies and in vitro photodynamic activities.

Q38777662

Nanoscale metal-organic framework for highly effective photodynamic therapy of resistant head and neck cancer

Q38939397

Synthesis and biological evaluation of some 2-(3,5-dimethyl-1H-pyrazol-1-yl)-1-arylethanones: antibacterial, DNA photocleavage, and anticancer activities.

Q38992967

In vivo targeted deep-tissue photodynamic therapy based on near-infrared light triggered upconversion nanoconstruct

Q39223759

Photodynamic activity of anthraquinones isolated from Heterophyllaea pustulata Hook f. (Rubiaceae) on MCF-7c3 breast cancer cells

Q39526177

Highly water-soluble and tumor-targeted photosensitizers for photodynamic therapy

Q40828114

Cell-specific and pH-activatable rubyrin-loaded nanoparticles for highly selective near-infrared photodynamic therapy against cancer

Q46964936

CONTRIBUTION OF PHOTODYNAMIC THERAPY IN WOUND HEALING: A SYSTEMATIC REVIEW.

Q47229997

P275